All the news Showing 10 of 639 articles from: Hepatitis CGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Metabolic disorders cause liver damage in people with HIV more often than viral hepatitis in lower-income countries Keith Alcorn / 01 March 2022 Liver fibrosis in people with HIV in low- and middle-income countries was more often attributable to metabolic disorders than viral hepatitis, a six-country comparative study has found.The findings, presented last ... Universal hepatitis C screening in pregnancy improves case detection Keith Alcorn / 23 February 2022 Implementing universal testing for hepatitis C during pregnancy improved case detection 7.5-fold compared to the previous regime of risk-based screening, a research group from the University of Pittsburgh reported last week at the ... New cases of hepatitis C declining in people with HIV as access to treatment broadens Keith Alcorn / 21 February 2022 The availability of direct-acting antivirals has led to a 50% reduction in new cases of hepatitis among people with HIV in some high-income settings, a six-country study presented this week ... Antihistamine use halved the risk of liver cancer in people with viral hepatitis Keith Alcorn / 08 February 2022 Antihistamines used for relief of allergies and hay fever halved the risk of developing hepatocellular carcinoma (HCC; liver cancer) in people with viral hepatitis during a ten-year follow-up period, a review of ... Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... Re-infection with hepatitis C has fallen among people with HIV in Europe Keith Alcorn / 20 January 2022 The rate of re-infection with hepatitis C has fallen sharply among people with HIV in Europe since the introduction of direct-acting antivirals, the EuroSIDA cohort study reports in the journal HIV Medicine. People ... One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... Australia on track to eliminate hepatitis C among gay and bisexual men before 2030 Krishen Samuel / 10 December 2021 Access to direct-acting antivirals to cure hepatitis C has slashed incidence rates for groups most affected in Australia. Among gay and bisexual men living with HIV, incidence fell by 78% ... Three-drug regimen plus ribavirin cures the hardest-to-treat hepatitis C patients Keith Alcorn / 08 December 2021 People who have experienced failure of multiple courses of direct-acting antiviral treatment can be cured of hepatitis C with a combination of three direct-acting antivirals plus ribavirin, a review of heavily treatment-experienced patients ... Cognitive function improves after hepatitis C cure Keith Alcorn / 22 October 2021 Curing hepatitis C improves cognitive function, especially in older people already showing signs of cognitive impairment, a Spanish study has found. Cognitive impairment covers a wide spectrum of problems with memory, concentration, learning, attention ... ← Prev12345...64Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive